RECENT NEWS

Vivo Surgical, a pioneering medical device company based in Singapore, has become the first start-up to win the prestigious WIPO-IPOS IP for Innovation Award for 2022.

Cardiologists at East Suffolk and North Essex NHS Foundation Trust (ESNEFT) are now able to carry out additional specialist tests to help diagnose heart problems following the introduction of new charity-funded equipment.

A new national centre of excellence to strengthen NHS cancer services by looking at treatments and patient outcomes right across the country will be established at the Royal College of Surgeons of England (RCS England).

High tech goggles will be worn by community nurses on home visits to free up time with patients, as part of a cutting-edge NHS pilot.

Over 50 new surgical hubs will open across the country to help tackle the COVID-19 backlogs and offer hundreds of thousands more patients quicker access to vital procedures, the Health and Social Care Secretary Steve Barclay has announced.

Seven new community diagnostic centres (CDCs) will open to help bust the COVID backlogs, diagnose patients more quickly and meet future demands on the NHS, the Health and Social Care Secretary has confirmed.

Taking place at the University of York and virtually from 8-11 September, the AfPP Annual Conference 2022 is set to be one of the largest gatherings of theatre practitioners in the professional (and social) calendar.

Surgical Holdings will be exhibiting at the Association for Perioperative Practice (AfPP) Annual Conference 2022 to raise awareness of their accredited training programme which highlights how to test the quality of rigid endoscopes, identify faults and ensure patient safety.

The Journal of Nature / Scientific Reports has published a paper from the Sunnybrook Research Institute in Toronto reporting that nasal antimicrobial photodynamic disinfection therapy (aPDT) effectively inactivated SARS-CoV-2 in the nose of patients with COVID-19.

A leading sepsis charity and a groundbreaking research project are marking the start of Sepsis Awareness Month (1 September 2022) by announcing a new pilot study which will provide invaluable data needed to improve treatments for sepsis patients.

Medicines used to treat serious and long term conditions are not being prescribed as often as they should be expected following the pandemic, raising fears that this could be causing avoidable deaths from heart disease and strokes.

Ethicon, the Surgical Technologies Company of Johnson & Johnson MedTech, is launching its first-ever roadshow across the UK & Ireland, including a showcase that demonstrates the role of digital innovation in supporting the NHS to tackle the backlog of patients waiting for treatment.

Fast-growing market disruptor Althea UK has landed a new backer in DWS infrastructure, forming a key part of the new pan-European healthcare group ‘Inframedica’.

NHS England, along with a consortium of partners, is inviting people from across England to give feedback on their recent experiences of using urgent and emergency care (UEC) services.

Health tech specialist Dignio has linked up with AliveCor to integrate its KardiaMobile device into the MyDignio smartphone app. The move will allow seamless transmission of electrocardiograms (ECG) recorded by patients in the community direct to clinicians.

Tork, Essity’s professional hygiene brand, has extended its partnership with the Infection Prevention Society (IPS) and Sodexo, to continue to deliver its Environment, Cleaning and Decontamination (ECD) programme for IPS members after a fruitful first year.

Smoking, alcohol use, high BMI, and other known risk factors were responsible for nearly 4.45 million global cancer deaths in 2019, according to new research published in The Lancet, using the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2019 study.

A new study led by the UK Health Security Agency has found that rates of Group B Streptococcal (GBS) disease are significantly higher in infants of Black or Asian ethnicity, compared to infants of White ethnicity.

The organisers of the HSJ Patient Safety Congress have confirmed a number of high-profile healthcare figures will be speaking at the event – taking place on 15-16 September in Manchester Central.

A new study has revealed for the first time the range and type of illnesses that people with type 2 diabetes (T2DM) are living with, highlighting that there is an urgent need for a more personalised and approach to care for those suffering with the disease.